Event Information

[ONTARIO EDITION] Precision Medicine in Prostate Cancer: Multidisciplinary Perspectives in Identifying, Managing and Optimizing Patient Care

Type
Speaker’s Tour

EVENT DETAILS

Display Date
Thursday November 18, 2021 /// 19:00-20:30 ET • 20:00-21:30 AT
Location
Virtual
Speaker
N. Fleshner, U. Emmenegger, E. Thain

ACCREDITATION

Accreditation
1.5 Section 1 Group Learning Credits
Event Description

image
 
Learning Objectives: 

  • Describe the significance and appropriate timing for testing for germline and somatic mutations in mCRPC
  • Evaluate the different modalities and avenues for testing
  • Review clinical safety and efficacy data for PARP inhibitors
  • Discuss the rationale for PARP inhibitor utilization in HRR-mutated mCRPC